Gunter Verheugen, the Vice President of the European Commission responsible for enterpise and industry, told a workshop organized by the Alliance for a Competitive Industry, in Brussels, Belgium, that the new European Industrial Policy aims to create a better climate for business, with sectoral strategies for signifant industries, including drugs. Although Mr Verheugen made clear that "this does not at all mean sheltering sectors from international competition," the EC has taken steps to ensure the "comprehensive protection of intellectual property rights and the effective fight against counterfeiting."
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze